An observational study in Urinary Tract Infections and Urinary Catheterization, sponsored by Central Hospital, Nancy, France. Recruiting at 1 site in France. Per ClinicalTrials.gov, last updated 2025-08-08.
Sponsored by Central Hospital, Nancy, France · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 58 studies in Urinary Tract Infections with a site in France — 10 open to participants now, 11 under way, 1 of them phase 3. Urinary Tract Infections · France.
Among the 58 studies in Urinary Tract Infections with a site in France, this one is the 9th largest by planned enrollment of the 23 observational ones that give a count, is one of 3 that started in 2024, is one of 23 observational ones, reaches primary completion later than 3 of the 10 other live ones, and was the 50th registered.
808 studies on the registry are indexed under Urinary Tract Infections; 135 are open to participants now.
Browse Urinary Tract Infections studies →10 of the 58 studies in Urinary Tract Infections with a site in France are open now. Recruiting first, the newest first:
University Hospital, Limoges · Sites in France
Ages 18+
Centre Hospitalier Intercommunal Creteil · Sites in France
Ages 18+
University Hospital, Strasbourg, France · Sites in France
Ages 18+
CNGE Conseil · Sites in France
Ages 18+
Nantes University Hospital · Sites in France
Ages 18+ · Women only
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 84 Urinary Tract Infections studies recruiting now, 51 (61%) set no upper age limit and 23 (27%) stop at 75 or younger; 17 take children under 18; 15 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
58 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 300 is above the median of 241 across 199 observational studies indexed under Urinary Tract Infections.
Median enrollment 131 across the 34 interventional studies, 200 across the 23 observational. Of the 41 that completed or were terminated, 2 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 58 have an industry lead sponsor. The 10 most frequent:
Central Hospital, Nancy, France is the lead sponsor of 801 studies on the registry; 188 are open to participants now.
Central Hospital, Nancy, France has 3 studies filed under Urinary Tract Infections — fewer than ten, so there is no comparison to draw.
1 of the studies in Urinary Tract Infections with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07559318Centre Hospitalier Intercommunal CreteilPost-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI) | 2027-01-01 |
Add it to your calendar (.ics) → With an account.
Among the 58 studies in Urinary Tract Infections with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The Committee of Infectiology of the French Association of Urology (CIAFU) provided, for the first time in 2020, comprehensive guidelines for ureteral stent-associated urinary tract infections (USAUTI) prevention, diagnosis and treatment. Since evidence lacked in terms of appropriate treatment, guidelines could not support systematic change of US in case of USAUTI.
This study aims to evaluate whether "after guidelines group" patients treated for USAUTI had different occurrence of at least one relapse or recurrence than "before guidelines group".
Groups will be selected from patients attending University Hospital of Nancy meeting the eligibility criteria during the period of inclusion running from January 1, 2018 to May 31, 2020 and from August 1, 2020 to December 31, 2022
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients treated for ureteral stent associated urinary tract infection in the University Hospital of Nancy from January 1, 2018 to May 31, 2020
Patients treated for ureteral stent associated urinary tract infection in the University Hospital of Nancy from August 1, 2020 to December 31, 2022
Other: Guidelines promoting surgical abstention
Guidelines promoting surgical abstention
Relapse OR recurrence of urinary tract infection
Time frame: 1 year
Nephro-urologic complication
Acute kidney injury ; hematuria ; pain ; stent migration or incrustation
Time frame: 1 year
Infectious complication
Sepsis or septic shock
Time frame: 1 year
In-hospital and 1-year mortality
all cause death
Time frame: 1 year
Resort to Watch or Reserve antibiotics
antibiotics' WHO classifcation
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
Ran from Jul 2024 to primary completion in Mar 2025, 8 months.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France →